Teva Board Members Take 50% Pay Cut Post author:Sam Post published:January 10, 2018 Post category:BioPharma Teva has made a target of cutting costs by $3B by the end of 2019. Source: BioSpace You Might Also Like Roche Gets in on Bay Area Allakos' $100M Funding Round December 12, 2017 K2M First-To-Market With 3D-Printed Corpectomy Cage System Following FDA Clearance Of CAPRI Small 3D Static Featuring Lamellar 3D Titanium Technology June 27, 2017 Flex Pharma To Report Second Quarter 2017 Results On August 2, 2017 July 25, 2017
K2M First-To-Market With 3D-Printed Corpectomy Cage System Following FDA Clearance Of CAPRI Small 3D Static Featuring Lamellar 3D Titanium Technology June 27, 2017
